biote Corp.
BTMD
$2.56
-$0.02-0.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -6.67% | -0.62% | 4.67% | 9.04% | 12.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.67% | -0.62% | 4.67% | 9.04% | 12.79% |
| Cost of Revenue | -11.39% | -9.67% | -6.26% | 2.13% | 7.84% |
| Gross Profit | -4.68% | 3.49% | 9.08% | 12.09% | 15.02% |
| SG&A Expenses | 10.99% | -10.86% | 16.43% | 24.37% | 15.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.10% | -10.43% | 8.04% | 16.25% | 12.24% |
| Operating Income | -32.77% | 62.94% | -7.07% | -28.67% | 14.47% |
| Income Before Tax | -46.70% | 159.01% | 625.12% | -113.07% | -32.58% |
| Income Tax Expenses | -123.92% | 2,845.21% | -32.72% | -71.39% | -17.45% |
| Earnings from Continuing Operations | -27.19% | 137.86% | 376.62% | -71.16% | -35.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 47.42% | -122.55% | -235.53% | 105.06% | 83.86% |
| Net Income | -23.49% | 144.94% | 429.68% | -52.12% | 42.12% |
| EBIT | -32.77% | 62.94% | -7.07% | -28.67% | 14.47% |
| EBITDA | -29.73% | 59.17% | -4.92% | -23.85% | 16.76% |
| EPS Basic | -24.19% | 146.99% | 462.48% | -47.98% | 38.88% |
| Normalized Basic EPS | -19.95% | -24.56% | -67.85% | 1,271.23% | 164.49% |
| EPS Diluted | -33.33% | 146.66% | 407.82% | -17.28% | 37.50% |
| Normalized Diluted EPS | -28.98% | -24.84% | -72.62% | 1,938.46% | 163.50% |
| Average Basic Shares Outstanding | 0.92% | -4.37% | -9.06% | -7.95% | 2.34% |
| Average Diluted Shares Outstanding | 13.79% | -4.02% | 6.74% | -41.14% | 3.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.98% | 1.85% | -- | -- | -0.68% |